ZHX1 Inhibits Gastric Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis

Xingjie Ma1, Minlu Huang1, Zhenqiang Wang1

  • 1Department of Surgery, Shanghai Key Laboratory of Gastric Neoplasms, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Journal of Cancer
|January 2, 2016
PubMed

Insights

Zinc-fingers and homeoboxes 1 (ZHX1) is downregulated in gastric cancer (GC), inhibiting tumor growth by inducing cell-cycle arrest and apoptosis. Loss of ZHX1 correlates with aggressive GC characteristics.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Zinc-fingers and homeoboxes 1 (ZHX1) is implicated in human cancer development.
  • The specific role of ZHX1 in gastric cancer (GC) remains largely uncharacterized.

Purpose of the Study:

  • To investigate the expression and function of ZHX1 in gastric cancer.
  • To determine the correlation between ZHX1 expression and clinical characteristics of GC patients.

Main Methods:

  • Analysis of ZHX1 expression in GC tissues versus non-tumor tissues.
  • Assessment of ZHX1's impact on cell-cycle progression and apoptosis.
  • Evaluation of key cell-cycle and apoptosis-related protein expression levels.

Main Results:

  • ZHX1 expression was significantly downregulated in GC tissues.
  • Loss of ZHX1 expression correlated with aggressive clinical features in GC patients.
  • ZHX1 induced G1/S cell-cycle arrest and promoted apoptosis by modulating proteins like cyclin D1, cyclin E, Bcl2, Bax, and cleaved Caspase-3.

Conclusions:

  • ZHX1 functions as a tumor suppressor in gastric cancer.
  • ZHX1 inhibits GC cell proliferation by inducing cell-cycle arrest and apoptosis.
  • ZHX1 represents a potential therapeutic target for gastric cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K